Evidence map›Paper›PMID 25803510›Full record

Trial reportPloS one2015

Circulating 20S proteasome is independently associated with abdominal muscle mass in hemodialysis patients.

Hirotaka Fukasawa, Mai Kaneko, Hiroki Niwa, Takashi Matsuyama, Hideo Yasuda, Hiromichi Kumagai, Ryuichi Furuya

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Concept and application of circulating proteasomes.Experimental & molecular medicine · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Hirotaka FukasawaRenal Division, Department of Internal Medicine, Iwata City Hospital, Iwata, Shizuoka, Japan.
Mai KanekoRenal Division, Department of Internal Medicine, Iwata City Hospital, Iwata, Shizuoka, Japan.
Hiroki NiwaRenal Division, Department of Internal Medicine, Iwata City Hospital, Iwata, Shizuoka, Japan.
Takashi MatsuyamaRenal Division, Department of Internal Medicine, Iwata City Hospital, Iwata, Shizuoka, Japan.
Hideo YasudaFirst Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Hiromichi KumagaiThe Department of Clinical Nutrition, School of Food and Nutritional Sciences, University of Shizuoka, Shizuoka, Shizuoka, Japan.
Ryuichi FuruyaRenal Division, Department of Internal Medicine, Iwata City Hospital, Iwata, Shizuoka, Japan.
Iwata City Hospital · JPHamamatsu University School of Medicine · JPUniversity of Shizuoka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledProtein-energy wasting is highly prevalent in hemodialysis patients, and it contributes to patient morbidity and mortality. The ubiquitin-proteasome system is the major pathway for intracellular protein degradation and it is involved in the regulation of basic cellular processes. However, the role of this system in the determination of nutritional status is largely unknown. To examine a relationship between protein-energy wasting and the ubiquitin-proteasome system, a cross-sectional study of 76 hemodialysis patients was performed. Plasma concentrations of 20S proteasome were studied to evaluate its association with muscle and fat mass, which were investigated by abdominal muscle and fat areas measured using computed tomography and by creatinine production estimated using the creatinine kinetic model. Plasma 20S proteasome concentrations significantly and negatively correlated with abdominal muscle areas and creatinine production (rho = -0.263, P < 0.05 and rho = -0.241, P < 0.05, respectively), but not abdominal subcutaneous and visceral fat areas. Multiple regression analyses showed that 20S proteasome was a significant independent predictor of abdominal muscle area (P < 0.05). In conclusion, plasma 20S proteasome concentrations were independently associated with abdominal muscle mass in hemodialysis patients. Our findings indicate a relationship between circulating 20S proteasomes and muscle metabolism in these patients.

trial registrationUMIN Clinical Trials Registry UMIN000012341.

Indexed as

Renal DialysisAbdominal MusclesAgedCreatinineCross-Sectional StudiesFemaleHumansKidney Failure, ChronicMaleMiddle AgedOrgan SizeProteasome Endopeptidase ComplexWasting SyndromeCreatinineProteasome Endopeptidase Complex

Identifiers

PMID25803510
PMCPMC4372611
OpenAlexW2050802797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.